Diagnosis of intrahepatic cholangiocarcinoma with CEUS

1. Buettner S, van Vugt JL, IJzermans JN, Groot Koerkamp B: Intrahepatic cholangiocarcinoma: current perspectives. Onco Targets Ther 2017; 10: 1131–1142. doi: 10.2147/ott.s93629. BuettnerS van VugtJL IJzermansJN Groot KoerkampB Intrahepatic cholangiocarcinoma: current perspectives Onco Targets Ther 2017 10 1131 1142 10.2147/ott.s93629 Open DOISearch in Google Scholar

2. Serra C, Righi S, Molo CD, Felicani C: Current role of contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. J Hepatol Gastroint Dis 2015; 1: 102. doi: 10.4172/2475-3181.1000102. SerraC RighiS MoloCD FelicaniC Current role of contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma J Hepatol Gastroint Dis 2015 1 102 10.4172/2475-3181.1000102 Open DOISearch in Google Scholar

3. Loria F, Loria G, Basile S, Crea G, Frosina L, Frosina F: Role of contrast-enhanced ultrasound in the evaluation of vascularization of hepatocellular carcinoma. Hepatoma Res 2016; 2: 316–322. doi: 10.20517/2394-5079.2016.27. LoriaF LoriaG BasileS CreaG FrosinaL FrosinaF Role of contrast-enhanced ultrasound in the evaluation of vascularization of hepatocellular carcinoma Hepatoma Res 2016 2 316 322 10.20517/2394-5079.2016.27 Open DOISearch in Google Scholar

4. Loria F, Parlati A, Loria G, Frosina L, Crea G, Basile S et al.: Role of the contrast-enhanced ultrasound in the diagnosis of HCC in cirrhotic liver. Hepatoma Res 2018; 4: 59. doi: 10.20517/2394-5079.2018.75. LoriaF ParlatiA LoriaG FrosinaL CreaG BasileS Role of the contrast-enhanced ultrasound in the diagnosis of HCC in cirrhotic liver Hepatoma Res 2018 4 59 10.20517/2394-5079.2018.75 Open DOISearch in Google Scholar

5. Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsøe CP et al.: Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver – update 2012. A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 2013; 39: 187–210. doi: 10.1016/j.ultrasmedbio.2012.09.002. ClaudonM DietrichCF ChoiBI CosgroveDO KudoM NolsøeCP Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver – update 2012. A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS Ultrasound Med Biol 2013 39 187 210 10.1016/j.ultrasmedbio.2012.09.002 Open DOISearch in Google Scholar

6. Cosgrove D, Harvey C.: Clinical uses of microbubbles in diagnosis and treatment. Med Biol Eng Comput 2009; 47: 813–826. doi: 10.1007/s11517-009-0434-3. CosgroveD HarveyC. Clinical uses of microbubbles in diagnosis and treatment Med Biol Eng Comput 2009 47 813 826 10.1007/s11517-009-0434-3 Open DOISearch in Google Scholar

7. Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, Calliada F et al.: Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) – update 2008. Ultraschall Med 2008; 29: 28–44. doi: 10.1055/s-2007-963785. ClaudonM CosgroveD AlbrechtT BolondiL BosioM CalliadaF Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) – update 2008 Ultraschall Med 2008 29 28 44 10.1055/s-2007-963785 Open DOISearch in Google Scholar

8. Simpson DH, Chin CT, Burns PN: Pulse inversion Doppler: a new method for detecting nonlinear echoes from microbubble contrast agents. IEEE Trans on Ultrason Ferroelectr Freq Control 1999; 46: 372–382. doi: 10.1109/58.753026. SimpsonDH ChinCT BurnsPN Pulse inversion Doppler: a new method for detecting nonlinear echoes from microbubble contrast agents IEEE Trans on Ultrason Ferroelectr Freq Control 1999 46 372 382 10.1109/58.753026 Open DOISearch in Google Scholar

9. Tiemann K, Lohmeier S, Kuntz S, Köster J, Pohl C, Burns P et al.: Real-time contrast echo assessment of myocardial perfusion at low emission power: first experimental and clinical results using power pulse inversion imaging. Echocardiography 1999; 16: 799–809. doi: 10.1111/j.1540-8175.1999.tb00132.x. TiemannK LohmeierS KuntzS KösterJ PohlC BurnsP Real-time contrast echo assessment of myocardial perfusion at low emission power: first experimental and clinical results using power pulse inversion imaging Echocardiography 1999 16 799 809 10.1111/j.1540-8175.1999.tb00132.x Open DOISearch in Google Scholar

10. Averkiou M, Powers J, Skyba D, Bruce M, Jensen S: Ultrasound contrast imaging research. Ultrasound Q 2003; 19: 27–37. doi: 10.1097/00013644-200303000-00004. AverkiouM PowersJ SkybaD BruceM JensenS Ultrasound contrast imaging research Ultrasound Q 2003 19 27 37 10.1097/00013644-200303000-00004 Open DOISearch in Google Scholar

11. Szabo T: Diagnostic ultrasound imaging: inside out. Academic Press, Amsterdam 2004. SzaboT Diagnostic ultrasound imaging: inside out Academic Press Amsterdam 2004 Search in Google Scholar

12. Dietrich CF, Ignee A, Hocke M, Schreiber-Dietrich D, Greis C: Pitfalls and arte-facts using contrast enhanced ultrasound. Z Gastroenterol 2011; 49: 350–356. doi: 10.1055/s-0029-1245851. DietrichCF IgneeA HockeM Schreiber-DietrichD GreisC Pitfalls and arte-facts using contrast enhanced ultrasound Z Gastroenterol 2011 49 350 356 10.1055/s-0029-1245851 Open DOISearch in Google Scholar

13. Busilacchi P, Rapaccini Idelson-Gnocchi GL (eds): Ecografia clinica, Naples 2006. BusilacchiP Rapaccini Idelson-GnocchiGL (eds) Ecografia clinica Naples 2006 Search in Google Scholar

14. Hu HT, Wang W, Chen LD, Ruan SM, Chen SL, Li X et al.: Artificial intelligence assists identifying malignant versus benign liver lesions using contrast-enhanced ultrasound. J Gastroenterol Hepatol 2021; 36: 2875–2883. doi: 10.1111/jgh.15522. HuHT WangW ChenLD RuanSM ChenSL LiX Artificial intelligence assists identifying malignant versus benign liver lesions using contrast-enhanced ultrasound J Gastroenterol Hepatol 2021 36 2875 2883 10.1111/jgh.15522 Open DOISearch in Google Scholar

15. Neumaier CE, Bertolotto M, Perrone R, Martinoli C, Loria F, Silvestri E: Staging of hilar cholangiocarcinoma with ultrasound. J Clin Ultrasound 1995; 23: 173–178. doi: 10.1002/jcu.1870230305. NeumaierCE BertolottoM PerroneR MartinoliC LoriaF SilvestriE Staging of hilar cholangiocarcinoma with ultrasound J Clin Ultrasound 1995 23 173 178 10.1002/jcu.1870230305 Open DOISearch in Google Scholar

16. Chi Z, Bhalla A, Saeed O, Cheng L, Curless K, Wang HL et al.: Mucinous intrahepatic cholangiocarcinoma: a distinct variant. Hum Pathol 2018; 78: 131–137. doi: 10.1016/j.humpath.2018.04.010. ChiZ BhallaA SaeedO ChengL CurlessK WangHL Mucinous intrahepatic cholangiocarcinoma: a distinct variant Hum Pathol 2018 78 131 137 10.1016/j.humpath.2018.04.010 Open DOISearch in Google Scholar

17. Loria F, Loria G, Basile S, Crea G, Randazzo D, Frosina L: Contrast-enhanced ultrasound of hepatocellular carcinoma: correlation between enhancement pattern and cellular differentiation on histopathlogy. Updates Surg 2012; 64: 247–255. doi: 10.1007/s13304-012-0179-7. LoriaF LoriaG BasileS CreaG RandazzoD FrosinaL Contrast-enhanced ultrasound of hepatocellular carcinoma: correlation between enhancement pattern and cellular differentiation on histopathlogy Updates Surg 2012 64 247 255 10.1007/s13304-012-0179-7 Open DOISearch in Google Scholar

18. Ainora ME, Cerrito L, Liguori A, Mignini I, De Luca A, Galasso L et al.: Multiparametric dynamic ultrasound approach for differential diagnosis of primary liver tumors. Int J Mol Sci 2023; 24: 8548. doi: 10.3390/ijms24108548. AinoraME CerritoL LiguoriA MigniniI De LucaA GalassoL Multiparametric dynamic ultrasound approach for differential diagnosis of primary liver tumors Int J Mol Sci 2023 24 8548 10.3390/ijms24108548 Open DOISearch in Google Scholar

19. Dong Y, Chen S, Möller K, Qiu YJ, Lu XY, Zhang Q et al.: Applications of dynamic contrast-enhanced ultrasound in differential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in non-cirrhotic liver. Ultrasound Med Biol 2023; 49: 1780–1788. doi: 10.1016/j.ultrasmedbio.2023.03.026. DongY ChenS MöllerK QiuYJ LuXY ZhangQ Applications of dynamic contrast-enhanced ultrasound in differential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in non-cirrhotic liver Ultrasound Med Biol 2023 49 1780 1788 10.1016/j.ultrasmedbio.2023.03.026 Open DOISearch in Google Scholar

20. Chammas MC, Bordini AL: Contrast-enhanced ultrasonography for the evaluation of malignant focal liver lesions. Ultrasonography 2022; 41: 4–24. doi: 10.14366/usg.21001. ChammasMC BordiniAL Contrast-enhanced ultrasonography for the evaluation of malignant focal liver lesions Ultrasonography 2022 41 4 24 10.14366/usg.21001 Open DOISearch in Google Scholar

21. D’Onofrio M, Rozzanigo U, Masinielli BM, Caffari S, Zogno A, Malagò R et al.: Hypoechoic focal liver lesions: characterization with contrast enhanced ultrasonography. J Clin Ultrasound 2005; 33: 164–172. doi: 10.1002/jcu.20111. D’OnofrioM RozzanigoU MasinielliBM CaffariS ZognoA MalagòR Hypoechoic focal liver lesions: characterization with contrast enhanced ultrasonography J Clin Ultrasound 2005 33 164 172 10.1002/jcu.20111 Open DOISearch in Google Scholar

22. Chen T, Chang X, Lv K, Wang Y, Fu X, Tan L et al.: Contrast-enhancement ultrasound features of intrahepatic cholangiocarcinoma: a new perspective. Sci Rep 2019; 9: 19363. doi: 10.1038/s41598-019-55857-6. ChenT ChangX LvK WangY FuX TanL Contrast-enhancement ultrasound features of intrahepatic cholangiocarcinoma: a new perspective Sci Rep 2019 9 19363 10.1038/s41598-019-55857-6 Open DOISearch in Google Scholar

23. Yuan MX, Li R, Zhang XH, Tang CL, Guo YL, Guo DY et al.: Factors affecting the enhancement patterns of intrahepatic cholangiocarcinoma (ICC) on Contrast-enhancement ultrasound (CEUS) and their pathological correlations in patients with a single lesion. Ultraschall Med 2016; 37: 609–618. doi: 10.1055/s-0034-1399485. YuanMX LiR ZhangXH TangCL GuoYL GuoDY Factors affecting the enhancement patterns of intrahepatic cholangiocarcinoma (ICC) on Contrast-enhancement ultrasound (CEUS) and their pathological correlations in patients with a single lesion Ultraschall Med 2016 37 609 618 10.1055/s-0034-1399485 Open DOISearch in Google Scholar

24. Jin C, Zhang XY, Li JW, Li C, Peng W, Wen TF et al.: Impact of tumor size and cirrhotic background for differentiating HCC and ICC with CEUS: does it matter for patients undergoing hepatectomy? Oncotarget 2017; 8: 83698–83711. doi: 10.18632/oncotarget.19624. JinC ZhangXY LiJW LiC PengW WenTF Impact of tumor size and cirrhotic background for differentiating HCC and ICC with CEUS: does it matter for patients undergoing hepatectomy? Oncotarget 2017 8 83698 83711 10.18632/oncotarget.19624 Open DOISearch in Google Scholar

25. Xu J, Sasaki M, Harada K, Sato Y, Ikeda H, Kim J et al.: Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis. Histopathology 2011; 59: 1090–1099. doi: 10.1111/j.1365-2559.2011.04058.x. XuJ SasakiM HaradaK SatoY IkedaH KimJ Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis Histopathology 2011 59 1090 1099 10.1111/j.1365-2559.2011.04058.x Open DOISearch in Google Scholar

26. Sun D, Xu Z, Cao S, Wu H, Lu M, Xu Q et al.: Imaging features based on CT and MRI for predicting prognosis of patients with intrahepatic cholangiocarcinoma: a single-center study and meta-analysis. Cancer Imaging2023; 23: 56. doi: 10.1186/s40644-023-00576-5. SunD XuZ CaoS WuH LuM XuQ Imaging features based on CT and MRI for predicting prognosis of patients with intrahepatic cholangiocarcinoma: a single-center study and meta-analysis Cancer Imaging 2023 23 56 10.1186/s40644-023-00576-5 Open DOISearch in Google Scholar

27. Frydrychowicz A, Lubner MG, Brown JJ, Merkle EM, Nagle SK, Rofsky NM et al.: Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging 2012; 35: 492–511. doi: 10.1002/jmri.22833. FrydrychowiczA LubnerMG BrownJJ MerkleEM NagleSK RofskyNM Hepatobiliary MR imaging with gadolinium-based contrast agents J Magn Reson Imaging 2012 35 492 511 10.1002/jmri.22833 Open DOISearch in Google Scholar

28. Xu HX, Chen LD, Liu LN, Zhang YF, Guo LH, Liu C: Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination. Br J Radiol 2012; 85: 1029–1037. doi: 10.1259/bjr/21653786. XuHX ChenLD LiuLN ZhangYF GuoLH LiuC Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination Br J Radiol 2012 85 1029 1037 10.1259/bjr/21653786 Open DOISearch in Google Scholar

29. Strobel D, Seitz K, Blank W, Schuler A, Dietrich C, von Herbay A et al.: Contrast-enhanced ultrasound for the characterization of focal liver lesions diagnostic accurancy in clinical practice (DEGUM multicentre trial). Ultraschell Med 2008; 29: 499–505. doi: 10.1055/s-2008-1027806. StrobelD SeitzK BlankW SchulerA DietrichC von HerbayA Contrast-enhanced ultrasound for the characterization of focal liver lesions diagnostic accurancy in clinical practice (DEGUM multicentre trial) Ultraschell Med 2008 29 499 505 10.1055/s-2008-1027806 Open DOISearch in Google Scholar

30. Sporea I, Badea R, Martie A, Dumitru E, Ioaniţescu S, Şirli R et al.: Contrast enhanced ultrasound for the evaluation of focal liver lesions in daily practice. A multicentre study. Med Ultrason 2012; 14: 95–100. doi: 10.1055/s-2008-1027806. SporeaI BadeaR MartieA DumitruE IoaniţescuS ŞirliR Contrast enhanced ultrasound for the evaluation of focal liver lesions in daily practice. A multicentre study Med Ultrason 2012 14 95 100 10.1055/s-2008-1027806 Open DOISearch in Google Scholar

31. Strobel D, Seitz K, Blank W, Schuler A, Dietrich C, von Herbay A et al.: Contrast-enhanced ultrasound for the characterization of focal liver lesions diagnostic accurancy in clinical practice (DEGUM multicentre trial). Ultraschell Med 2008; 29: 499–505. doi: 10.1055/s-2008-1027806. StrobelD SeitzK BlankW SchulerA DietrichC von HerbayA Contrast-enhanced ultrasound for the characterization of focal liver lesions diagnostic accurancy in clinical practice (DEGUM multicentre trial) Ultraschell Med 2008 29 499 505 10.1055/s-2008-1027806 Open DOISearch in Google Scholar

32. Dietrich CF, Kratzer W, Strobel D, Danse E, Fessl R, Bunk A et al.: Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus TC and MRI. World J Gastroenterol 2006; 12: 1699–1705. doi: 10.3748/wjg.v12.i11.1699. DietrichCF KratzerW StrobelD DanseE FesslR BunkA Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus TC and MRI World J Gastroenterol 2006 12 1699 1705 10.3748/wjg.v12.i11.1699 Open DOISearch in Google Scholar

33. Sangiovanni A, Manini MA, Iavarone M, Romeo R, Forzenigo LV, Fraquelli M et al.: The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 2010; 59: 638–644. doi: 10.1136/gut.2009.187286. SangiovanniA ManiniMA IavaroneM RomeoR ForzenigoLV FraquelliM The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis Gut 2010 59 638 644 10.1136/gut.2009.187286 Open DOISearch in Google Scholar

34. Bruix J, Sherman M: Management of hepatocellular carcinoma. Hepatology 2005; 41: 1208–1236. doi: 10.1002/hep.20933. BruixJ ShermanM Management of hepatocellular carcinoma Hepatology 2005 41 1208 1236 10.1002/hep.20933 Open DOISearch in Google Scholar

35. Vilana R, Forner A, Bianchi L, García-Criado A, Rimola J, de Lope CR et al.: Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology 2010; 51: 2020–2029. doi: 10.1002/hep.23600. VilanaR FornerA BianchiL García-CriadoA RimolaJ de LopeCR Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound Hepatology 2010 51 2020 2029 10.1002/hep.23600 Open DOISearch in Google Scholar

36. Bruix J, Sherman M: Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020–1022. doi: 10.1002/hep.24199. BruixJ ShermanM Management of hepatocellular carcinoma: an update Hepatology 2011 53 1020 1022 10.1002/hep.24199 Open DOISearch in Google Scholar

37. Galassi M, Iavarone M, Rossi S, Bota S, Vavassori S, Rosa L et al.: Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrosi at contrast enhanced ultrasound. Liver Int 2013; 33: 771–779. doi: 10.1111/liv.12124. GalassiM IavaroneM RossiS BotaS VavassoriS RosaL Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrosi at contrast enhanced ultrasound Liver Int 2013 33 771 779 10.1111/liv.12124 Open DOISearch in Google Scholar

38. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer: EASL-EORTC Clinical practice guidelines management of hepatocellular carcinoma. J Hepatol 2012; 56: 908–943. doi: 10.1016/j.jhep.2011.12.001. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer EASL-EORTC Clinical practice guidelines management of hepatocellular carcinoma J Hepatol 2012 56 908 943 10.1016/j.jhep.2011.12.001 Open DOISearch in Google Scholar

39. Barreiros AP, Piscaglia F, Dietrich CF: Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines. J Hepatol 2012; 57: 930–932. doi: 10.1016/j.jhep.2012.04.018. BarreirosAP PiscagliaF DietrichCF Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines J Hepatol 2012 57 930 932 10.1016/j.jhep.2012.04.018 Open DOISearch in Google Scholar

40. Li R, Yuan M-X, Ma K-S, Li X-W, Tang C-L, Zhang X-H et al.: Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis. PLoS One 2014; 9: e98612. doi: 10.1371/journal.pone.0098612. LiR YuanM-X MaK-S LiX-W TangC-L ZhangX-H Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis PLoS One 2014 9 e98612 10.1371/journal.pone.0098612 Open DOISearch in Google Scholar

41. He C, Zhang Y, Song Y, Wang J, Xing K, Lin X et al.: Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma. J Cancer 2018; 9: 3117–3128. doi: 10.7150/jca.25339. HeC ZhangY SongY WangJ XingK LinX Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma J Cancer 2018 9 3117 3128 10.7150/jca.25339 Open DOISearch in Google Scholar

42. Zong J, Fan Z, Zhang Y: Serum tumor markers for early diagnosis of primary hepatocellular carcinoma. J Hepatocell Carcinoma 2020; 7: 413–422. doi: 10.2147/jhc.s272762. ZongJ FanZ ZhangY Serum tumor markers for early diagnosis of primary hepatocellular carcinoma J Hepatocell Carcinoma 2020 7 413 422 10.2147/jhc.s272762 Open DOISearch in Google Scholar

43. Hu J, Bhayana D, Burak KW, Wilson SR: Resolution of indeterminate MRI with CEUS in patients at high risk for hepatocellular carcinoma. Abdom Radiol (NY) 2020; 45: 123–133. doi: 10.1007/s00261-019-02181-2. HuJ BhayanaD BurakKW WilsonSR Resolution of indeterminate MRI with CEUS in patients at high risk for hepatocellular carcinoma Abdom Radiol (NY) 2020 45 123 133 10.1007/s00261-019-02181-2 Open DOISearch in Google Scholar

44. Dietrich CF, Nolsøe CP, Barr RG, Berzigotti A, Burns PN, Cantisani V et al.: Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) in the liver-update 2020 WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultrasound Med Biol 2020; 46: 2579–2604. doi: 10.1016/j.ultrasmedbio.2020.04.030. DietrichCF NolsøeCP BarrRG BerzigottiA BurnsPN CantisaniV Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) in the liver-update 2020 WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS Ultrasound Med Biol 2020 46 2579 2604 10.1016/j.ultrasmedbio.2020.04.030 Open DOISearch in Google Scholar

45. Giorgio A, Gatti P, Montesarchio L, Santoro B, Dell’Olio A, Crucinio N et al.: Intrahepatic cholangiocarcinoma and thermal ablation: long-term results of an italian retrospective multicenter study. J Clin Transl Hepatol 2019; 7: 287–292. doi: 10.14218/jcth.2019.00036. GiorgioA GattiP MontesarchioL SantoroB Dell’OlioA CrucinioN Intrahepatic cholangiocarcinoma and thermal ablation: long-term results of an italian retrospective multicenter study J Clin Transl Hepatol 2019 7 287 292 10.14218/jcth.2019.00036 Open DOISearch in Google Scholar

46. Kim YS, Lim HK, Rhim H, Lee MW, Choi D, Lee WJ et al.: Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol 2013; 58: 89–97. doi: 10.1016/j.jhep.2012.09.020. KimYS LimHK RhimH LeeMW ChoiD LeeWJ Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors J Hepatol 2013 58 89 97 10.1016/j.jhep.2012.09.020 Open DOISearch in Google Scholar

47. Loria F, Loria G, Crea G, Basile S, Frosina F, Messina F et al.: Vascolarizzazione dell’epatocarcinoma: ruolo della CEUS e della TC multifasica. Giornale Italiano Radiol Med 2014; 1; 961–967. LoriaF LoriaG CreaG BasileS FrosinaF MessinaF Vascolarizzazione dell’epatocarcinoma: ruolo della CEUS e della TC multifasica Giornale Italiano Radiol Med 2014 1 961 967 Search in Google Scholar

48. Vidili G, Arru M, Solinas G, Calvisi DF, Meloni P, Sauchella A et al.: Contrast-enhanced ultrasound liver imaging reporting and data system: lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis. World J Gastroenterol 2022; 28: 3488–3502. doi: 10.3748/wjg.v28.i27.3488. VidiliG ArruM SolinasG CalvisiDF MeloniP SauchellaA Contrast-enhanced ultrasound liver imaging reporting and data system: lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis World J Gastroenterol 2022 28 3488 3502 10.3748/wjg.v28.i27.3488 Open DOISearch in Google Scholar

49. Li J, Yu Y, He Q: The auxiliary diagnosis and imaging characteristics of mri combined with ct in patients with cholangiocarcinoma. J Oncol 2021; 2021: 2790958. doi: 10.1155/2021/2790958. LiJ YuY HeQ The auxiliary diagnosis and imaging characteristics of mri combined with ct in patients with cholangiocarcinoma J Oncol 2021 2021 2790958 10.1155/2021/2790958 Open DOISearch in Google Scholar

50. Lee SW, Kim HJ, Park JH, Park DI, Cho YK, Sohn CI et al.: Clinical usefulness of ¹⁸F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma. J Gastroenterol 2010; 45: 560–566. doi: 10.1007/s00535-009-0188-6. LeeSW KimHJ ParkJH ParkDI ChoYK SohnCI Clinical usefulness of ¹⁸F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma J Gastroenterol 2010 45 560 566 10.1007/s00535-009-0188-6 Open DOISearch in Google Scholar

51. Kim YY, Yeom SK, Shin H, Choi SH, Rhee H, Park JH et al.: Clinical staging of mass-forming intrahepatic cholangiocarcinoma: computed tomography versus magnetic resonance imaging. Hepatol Commun 2021; 5: 2009–2018. doi: 10.1002/hep4.1774. KimYY YeomSK ShinH ChoiSH RheeH ParkJH Clinical staging of mass-forming intrahepatic cholangiocarcinoma: computed tomography versus magnetic resonance imaging Hepatol Commun 2021 5 2009 2018 10.1002/hep4.1774 Open DOISearch in Google Scholar

52. Nishioka E, Tsurusaki M, Kozuki R, Im S-W, Kono A, Kitajima K et al.: Comparison of conventional imaging and 18f-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnostic accuracy of staging in patients with intrahepatic cholangiocarcinoma. Diagnostics (Basel) 2022; 12: 2889. doi: 10.3390/diagnostics12112889. NishiokaE TsurusakiM KozukiR ImS-W KonoA KitajimaK Comparison of conventional imaging and 18f-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnostic accuracy of staging in patients with intrahepatic cholangiocarcinoma Diagnostics (Basel) 2022 12 2889 10.3390/diagnostics12112889 Open DOISearch in Google Scholar

53. Petrowsky H, Wildbrett P, Husarik DB, Hany TF, Tam S, Jochum W et al.: Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 2006; 45: 43–50. doi: 10.1016/j.jhep.2006.03.009. PetrowskyH WildbrettP HusarikDB HanyTF TamS JochumW Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma J Hepatol 2006 45 43 50 10.1016/j.jhep.2006.03.009 Open DOISearch in Google Scholar

54. Ke C, Yang T, Huang G, Gu C: Investigation of the accuracy of magnetic resonance cholangiography and multi-slice spiral computed tomography in the diagnosis of cholangiocarcinoma. J Gastrointest Oncol 2023; 14: 1496–1503. doi: 10.21037/jgo-22-1294. KeC YangT HuangG GuC Investigation of the accuracy of magnetic resonance cholangiography and multi-slice spiral computed tomography in the diagnosis of cholangiocarcinoma J Gastrointest Oncol 2023 14 1496 1503 10.21037/jgo-22-1294 Open DOISearch in Google Scholar